Zang R - Search Results

1

Incorporation of pazopanib in maintenance therapy of ovarian cancer.

du Bois A, Floquet A, Kim JW, Rau J, del Campo JM, Friedlander M, Pignata S, Fujiwara K, Vergote I, Colombo N, Mirza MR, Monk BJ, Kimmig R, Ray-Coquard I, Zang R, Diaz-Padilla I, Baumann KH, Mouret-Reynier MA, Kim JH, Kurzeder C, Lesoin A, Vasey P, Marth C, Canzler U, Scambia G, Shimada M, Calvert P, Pujade-Lauraine E, Kim BG, Herzog TJ, Mitrica I, Schade-Brittinger C, Wang Q, Crescenzo R, Harter P. du Bois A, et al. Among authors: zang r. J Clin Oncol. 2014 Oct 20;32(30):3374-82. doi: 10.1200/JCO.2014.55.7348. Epub 2014 Sep 15. J Clin Oncol. 2014. PMID: 25225436 Clinical Trial.

2

Cytoreductive surgery for stage IV epithelial ovarian cancer.

Zang RY, Zhang ZY, Cai SM, Li ZT, Chen J, Tang MQ, Liu Q. Zang RY, et al. J Exp Clin Cancer Res. 1999 Dec;18(4):449-54. J Exp Clin Cancer Res. 1999. PMID: 10746968

3

[Clinical significance of secondary cytoreductive surgery for recurrent advanced ovarian cancer].

Zang R, Zhang Z, Cai S. Zang R, et al. Zhonghua Zhong Liu Za Zhi. 2002 Mar;24(2):194-6. Zhonghua Zhong Liu Za Zhi. 2002. PMID: 12015048 Chinese.

4

Recurrent ovarian carcinoma of low malignant potential: the role of secondary surgical cytoreduction and the prognosis in Chinese patients.

Zang RY, Yang WT, Shi DR, Xing Y, Cai SM. Zang RY, et al. J Surg Oncol. 2005 Jul 1;91(1):67-72. doi: 10.1002/jso.20280. J Surg Oncol. 2005. PMID: 15999350

5

[Impacts of chemotherapy on long-term survival of patients with advanced epithelial ovarian cancer].

Zang R, Cai S, Zhang Z. Zang R, et al. Zhonghua Fu Chan Ke Za Zhi. 2001 Dec;36(12):738-41. Zhonghua Fu Chan Ke Za Zhi. 2001. PMID: 16136895 Chinese.

6

Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors.

Jiang R, Tang J, Cheng X, Zang RY. Jiang R, et al. Among authors: zang ry. Eur J Surg Oncol. 2009 Jan;35(1):92-7. doi: 10.1016/j.ejso.2008.05.006. Epub 2008 Jul 16. Eur J Surg Oncol. 2009. PMID: 18632244

7

Recurrence patterns and prognostic factors in Chinese patients with squamous cell carcinoma of the vulva treated with primary surgery.

Cheng X, Zang R, Wu X, Li Z, Cai S, Zhang Z. Cheng X, et al. Among authors: zang r. Int J Gynecol Cancer. 2009 Jan;19(1):158-62. doi: 10.1111/IGC.0b013e3181996a78. Int J Gynecol Cancer. 2009. PMID: 19258959

8

The role of secondary cytoreductive surgery for recurrent mucinous epithelial ovarian cancer (mEOC).

Cheng X, Jiang R, Li ZT, Tang J, Cai SM, Zhang ZY, Tian WJ, Zang RY. Cheng X, et al. Among authors: zang ry. Eur J Surg Oncol. 2009 Oct;35(10):1105-8. doi: 10.1016/j.ejso.2009.03.010. Epub 2009 May 13. Eur J Surg Oncol. 2009. PMID: 19443175

9

Surgery in recurrent epithelial ovarian cancer: benefits on Survival for patients with residual disease of 0.1-1 cm after secondary cytoreduction.

Tian WJ, Jiang R, Cheng X, Tang J, Xing Y, Zang RY. Tian WJ, et al. Among authors: zang ry. J Surg Oncol. 2010 Mar 1;101(3):244-50. doi: 10.1002/jso.21491. J Surg Oncol. 2010. PMID: 20112269

10

A risk model for secondary cytoreductive surgery in recurrent ovarian cancer: an evidence-based proposal for patient selection.

Tian WJ, Chi DS, Sehouli J, Tropé CG, Jiang R, Ayhan A, Cormio G, Xing Y, Breitbach GP, Braicu EI, Rabbitt CA, Oksefjell H, Fotopoulou C, Meerpohl HG, du Bois A, Berek JS, Zang RY, Harter P. Tian WJ, et al. Among authors: zang ry. Ann Surg Oncol. 2012 Feb;19(2):597-604. doi: 10.1245/s10434-011-1873-2. Epub 2011 Jul 6. Ann Surg Oncol. 2012. PMID: 21732142

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

331 results

Search Page